Life Extension Magazine June 2009
Physician’s Guide: Using Blood Test Findings To Safely Induce Weight Loss
By William Faloon
By William Faloon
Weight Loss Might Not be Possible if Thyroid Hormone Levels Are Insufficient
The thyroid gland secretes hormones involved in cellular energy expenditure. When a person restricts their calorie intake (i.e. goes on a diet), there is often a decrease in metabolically active thyroid hormone that causes the body’s fat-burning processes to slow down.
One reason people put on weight as they grow older is because aging impairs their ability to efficiently utilize carbohydrates and fats. One cause of impaired carbohydrate and lipid metabolism is sub-clinical thyroid deficiency. Some physicians believe that most people over 40 have a sub-clinical thyroid deficiency that contributes to their unwanted weight gain.109,110
To give you an idea of how profoundly the thyroid gland dictates body weight, consider that when the thyroid produces too much thyroid hormone, the most common clinical symptom is significant weight loss. The name for the disease caused by an overactive thyroid gland is hyperthyroidism, and in 76–83% of cases, a patient’s first complaint to their physician is about how much weight they have been losing.
In the 1960s and 1970s, the connection between hypothyroidism and weight gain caused some people to assume they could speed up their metabolism and lose weight by using supplemental thyroid hormones. This led to an abuse of thyroid hormone as people created an artificial state of excess thyroid hormone (a condition medically known as hyperthyroidism). Hyperthyroidism can cause weight loss as well as irregular heartbeats, sweating, and tremors. Although people taking supplemental thyroid hormones in these studies may have lost weight, they were losing lean muscle mass in addition to undesirable body fat.111
Today our understanding of the relationship between thyroid hormone and weight loss is more complete. It works like this: when calorie intake is drastically lowered, the activity of an enzyme called 5’-monodeiodinase is reduced; 5’-monodeiodinase is necessary to convert the thyroid hormone T4 into T3. When 5’-monodeiodinase level are reduced, the levels of T3 drop.112-115 T3 is the stronger form of thyroid hormone.
Decreased T3 levels can be directly replaced. Some older clinical studies testing this theory were promising. However, later studies showed that direct T3 supplementation by dieters was connected with muscle wasting.116,117 During fasting, administration of large doses of T3 caused even more severe muscle wasting.118
More recent studies suggest that using very low doses of replacement thyroid hormone during dieting, once the body has switched over from carbohydrate burning to fat burning, may not be associated with muscle breakdown.119-121
How to Prescribe Thyroid Hormones
While there are studies showing that thyroid supplementation promotes weight loss in some people, it should only be used when there is evidence of a thyroid hormone imbalance, either in the form of decreased secretion from the thyroid gland or decreased conversion of T4 to the metabolically active T3 in the peripheral tissues. It is important to remember that many people’s metabolic rate decreases in response to dieting, as their body attempts to slow the metabolic rate to conserve body mass.
That means a person with normal thyroid status before dieting may become thyroid-deficient because of the reduced intake of calories. This may occur when drugs like metformin or natural products are used to suppress appetite. For optimal fat-loss effects, a person may be prescribed small doses of Cytomel® (a prescription form of T3) if their T3 levels are not in the upper one-third range of normal, or if consuming fewer calories results in a reduction of T3 levels.
There are several blood tests used to assess thyroid function. If any of these tests indicate a thyroid deficiency, consider prescribing the appropriate dose of the drug Cytomel® (T3) or Armour® desiccated thyroid to bring your patient’s level into the normal range.
If a blood test shows an increase in thyroid-stimulating hormone (TSH), this means that the pituitary gland is over-secreting a hormone to stimulate thyroid function because of an apparent thyroid deficiency. The normal range for TSH can be as wide as 0.2–5.5 mIU/mL. However, if TSH levels are above 2.0, this indicates the patient may be hypothyroid and could benefit from Cytomel® or Armour® drug therapy. Remember, the higher the TSH blood level, the more likely the patient is to be thyroid-deficient.
T4 (or free thyroxine) tests the biologically available hormone being secreted by the thyroid gland. If T4 is deficient, most doctors prescribe Synthroid®, which is a synthetic T4 hormone. We recommend Cytomel® (T3) or Armour® desiccated thyroid, however, instead of Synthroid® (T4) because T3 is the metabolically active form of thyroid that aids in thermogenesis (body fat burning).122 When evaluating T4 blood test results, optimal levels for males seeking to lose weight should be in a range of 8.5–10.5 mcg/dL. Females under age 60 seeking to lose weight should be in the range of 9–11 mcg/dL. Women older than 60 years should be in the range of 8.5–10.7 mcg/dL. If there is too much T4, this is a sign of hyperthyroidism that should receive immediate medical treatment.
Measuring the amount of T3 is one way of ascertaining how much metabolically active thyroid hormone is available to the tissues. The normal free T3 range is 2.3–4.2 pg/mL, but for losing weight, you might want a range of 3.4–4.2 pg/mL. If the patient’s blood levels are below this, then Cytomel® drug therapy should be considered. Some patients are started with 12.5 mcg of Cytomel® twice a day. The dose can be increased if blood T3 levels do not return to a normal range or if symptoms of thyroid deficiency persist. If T3 levels are above normal, this can indicate an overdose of drugs like Synthroid® or Cytomel, or hyperthyroidism.
It should be emphasized that thyroid hormone by itself does not induce fat loss. Human clinical studies show that when thyroid hormone is given in the absence of thyroid insufficiency, muscle tissue is depleted.111,116,118 The purpose of testing a patient’s thyroid hormone status is to ensure they are in the optimal range (upper one-third of the normal reference range for T3).
Suppressing Obesity-Inducing Inflammatory Factors
In recent years, C-reactive protein (CRP) has emerged as a reliable marker of many age-related diseases that have a hidden inflammatory component, such as heart disease and cancer. However, scientists are now realizing that CRP may also play a more direct role in disease by contributing to the growing obesity epidemic.
In a recent breakthrough, scientists from the University of Pittsburgh have discovered that CRP interacts directly with a key hormone in the body called leptin, which signals satiety as well as promotes the breakdown of fat.123 By binding to leptin, the researchers conclude that CRP blocks its ability to pass through the blood-brain barrier to reach the hypothalamus and turn off chronic hunger signals, effectively interfering with leptin’s ability to regulate body weight. These exciting results reveal the importance of controlling CRP levels as part of a successful weight-management strategy.
Indeed, studies using the dietary supplement Irvingia gabonensis have shown a dramatic reduction in weight accompanied by a marked decline in CRP levels.124-126 Medications such as orlistat, metformin, and the carbohydrate enzyme-inhibiting agents can also reduce CRP.127,128 There are several nutritional approaches that offer a safe and effective means of reducing CRP levels:
Restoring Insulin Sensitivity and Further Reducing Postprandial Triglycerides
Metformin is an oral hypoglycemic drug that helps lower blood sugar levels in people with type 2 diabetes. It is a member of a class of antidiabetic agents originally derived from a plant called French lilac (Galega officinalis), which has been known for centuries to improve symptoms of diabetes.142,143 But, as with so many other substances (both supplements and prescription drugs), metformin has some unexpected and beneficial side effects when it comes to weight loss.
Recognizing that metformin-treated diabetics often lose weight, and believing that the drug might reduce patients’ food intake, researchers at the St. Louis University Medical Center explored possible mechanisms for this effect in 1998.144 Twelve obese women with type 2 diabetes who were on no medication were randomly assigned to receive oral metformin (850 or 1,700 mg) or placebo at 8:00 a.m. for three days. After a six-hour fast on the third day, subjects were given a “meal test” at 2:00 p.m., at which they were offered sandwich canapés. Just before, the meal subjects rated their hunger on a standard scale, and researchers then recorded the number of sandwiches the subjects ate in three consecutive 10-minute periods. Subjects who had taken metformin at either dose had significantly decreased calorie intake compared with placebo recipients, with the higher dose producing the most marked effect. Metformin-treated subjects also rated their hunger as lower, with the 1,700 mg/day dose producing the greatest decrease.
The researchers then went on to study 48 similar obese diabetic women who had not lost weight using diet alone. These subjects were given a 1,200-calorie diet and then were started on metformin (850 mg) or placebo twice daily for 24 weeks. The metformin-treated patients lost weight continuously throughout the treatment period, with a mean maximum weight loss that was 17.6 pounds greater than the placebo group. Not surprisingly, the metformin recipients also had lower fasting blood glucose levels as well as lower levels of the hemoglobin A1C molecule that is a marker of chronic blood sugar levels. The authors of this study concluded that “metformin decreases calorie intake in a dose-dependent manner and leads to a reduction in bodyweight in non-insulin dependent diabetic patients with obesity.”144
Metformin’s health benefits now appear to extend beyond simple weight loss—other studies are showing that it can beneficially affect a variety of other parameters that are disturbed by obesity. A group of Turkish researchers, for example, writing in Internal Medicine in 2008, demonstrated that, in addition to weight loss, metformin-treated obese subjects had highly significant decreases in hypertension, disruptions of lipid profiles, and fasting blood sugar levels compared with placebo-treated subjects. These researchers ended their report with the statement that “metformin treatment should be initiated in patients with excess weight in their fifties.”145 While that may be a bit over-enthusiastic, it does highlight the excitement that is being generated by this drug.
A Mexican research group has made similar findings with greater precision. They treated 60 obese patients with the metabolic syndrome (a constellation of findings related to obesity and its consequences), giving them metformin 850 mg/day or placebo, along with dietary counseling for all patients. They followed the patients for one year, tracking vital indicators of obesity-related cardiovascular health such as BMI, waist circumference, blood pressure, lipid profiles, blood sugar, and markers of the oxidant stress and inflammation that are cardinal features of the metabolic syndrome. Both groups lost weight and had improved blood pressures during the study, but patients taking metformin also had reductions in total cholesterol, markers of oxidation and CRP, a critical marker of inflammation related to vascular health. Perhaps most impressively, treated patients also had significant reductions in their intima-media thickness (IMT), which is a direct measure of blood vessel health reflecting the vessels’ actual reaction to metabolic risk factors. Not surprisingly these researchers concluded that “metformin has a considerable beneficial effect on nitroxidation, endothelial function and IMT in patients with metabolic syndrome.”146
Metformin has been used by healthy anti-aging enthusiasts since the early 1990s. Its ability to reduce glucose and insulin levels have led some to postulate that metformin may mimic some of the beneficial effects of caloric restriction. There are relatively few contraindications for prescribing metformin. Our only concern vis-à-vis this comprehensive weight-loss protocol we are proposing are hyper-responders to the alpha-glucosidase and alpha-amylase inhibitors who also overly respond to metformin. There is a theoretical risk of inducing a state of hypoglycemia when all three agents are combined. In the real world setting, however, most overweight and obese patients will already suffer from some degree of glucose impairment and should benefit greatly from all three of these treatment modalities. A safe starting dose of metformin would be 250 mg twice a day before a meal. If glucose levels are not overly suppressed, the metformin dose can be increased to as high as 850 mg two or even three times a day before meals.
An undesirable side effect of metformin for men is that it can reduce testosterone levels.147 As you read earlier in this article, low testosterone predisposes aging men to abdominal obesity. This may be why metformin has not always produced significant weight loss in clinical studies. Men who are prescribed testosterone replacement therapy can readily overcome this side effect if blood tests reveal that the prescribed dose of testosterone is not increasing free testosterone blood levels to the optimal 20-25 pg/mL range. All the prescribing doctor has to do is slightly increase the testosterone dose to overcome the testosterone-reducing effect of the metformin.